Breath Gas Analysis for the Diagnosis of Breast Cancer

Mamma Carcinoma Clinical Trial

Official title: Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos

Status Terminated

Clinical Trial Summary

The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry.

The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Mamma Carcinoma

• NCT number: NCT01105468
• Study type: Observational
• Source: Ionimed Analytik GmbH
• Status: Terminated
• Phase: N/A
• Start date: April 2010
• Completion date: April 2017